Telik Inc. (TELK)
-NasdaqCM 1.41 
0.04(2.75%) 12:28PM EDT - Nasdaq Real Time Price
| Prev Close: | 1.45 |
|---|
| Open: | 1.42 |
|---|
| Bid: | 1.40 x 2700 |
|---|
| Ask: | 1.44 x 100 |
|---|
| 1y Target Est: | 1.05 |
|---|
| Beta: | 0.15 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 1.37 - 1.42 |
|---|
| 52wk Range: | 1.09 - 3.18 |
|---|
| Volume: | 8,681 |
|---|
| Avg Vol (3m): | 38,969 |
|---|
| Market Cap: | 6.43M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.74 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- TELIK INC FinancialsEDGAR Online Financials(Tue, May 21)
- TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of SecurityEDGAR Online(Mon, May 20)
- Telik Announces First Quarter 2013 Financial ResultsPR Newswire(Fri, May 10)
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 10)
- Telik: A Possible Investment, But Only After Much Considerationat Seeking Alpha(Fri, Apr 5)
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, Mar 15)
- Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial GuidancePR Newswire(Fri, Mar 15)
- TELIK INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Tue, Mar 5)
- TELIK INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Fri, Feb 22)
- Is There Value In Telik?at Seeking Alpha(Thu, Jan 24)
- 4 Healthcare Stock Stories for Wednesday Wellnessat Wall St. Cheat Sheet(Wed, Jan 23)
- TELIK INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Jan 23)
- The Long And Short Cases For Telikat Seeking Alpha(Wed, Jan 16)
- Between A Rock And A Hard Place: Telik Needs Cashat Seeking Alpha(Mon, Jan 14)
- Is It Time To Go Long Or Short Telik?at Seeking Alpha(Sun, Jan 13)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Telik, Inc., a clinical-stage drug development company, engages in the discovery and development of small molecule drugs to treat cancer. The companys lead drug product candidate in clinical development includes TELINTRA, a small molecule gl...
View More